Dr. Faisal Alagrafi is a Senior Researcher at the Healthy Aging Research Institute, King Abdulaziz City for Science and Technology (KACST), Saudi Arabia, with over 17 years of experience in biomedical research. He holds a PhD in Medical Science (Clinical Immunology) from Karolinska Institutet, Sweden, and an MSc in Cell Biology, Genetics, and Histology from King Saud University.
His research focuses on cellular immunology, particularly γδ T-cell biology, immune reconstitution following allogeneic hematopoietic stem cell transplantation (HSCT), and cancer immunotherapy. His work includes investigating γδ T-cell phenotypic and clonal diversity, their association with clinical outcomes, and their therapeutic potential in hematological malignancies.
His current research interests include developing innovative immunotherapeutic strategies using γδ T cells, bispecific antibodies, and combination therapies to enhance antitumor immune responses. He is also interested in translational biomedical research, biotechnology, and the development of advanced cell-based therapies
Dr. Faisal Alagrafi is a Senior Researcher at the Healthy Aging Research Institute, King Abdulaziz City for Science and Technology (KACST), Saudi Arabia, with over 17 years of experience in biomedical research. He holds a PhD in Medical Science (Clinical Immunology) from Karolinska Institutet, Sweden, and an MSc in Cell Biology, Genetics, and Histology from King Saud University.
His research focuses on cellular immunology, particularly γδ T-cell biology, immune reconstitution following allogeneic hematopoietic stem cell transplantation (HSCT), and cancer immunotherapy. His work includes investigating γδ T-cell phenotypic and clonal diversity, their association with clinical outcomes, and their therapeutic potential in hematological malignancies.
His current research interests include developing innovative immunotherapeutic strategies using γδ T cells, bispecific antibodies, and combination therapies to enhance antitumor immune responses. He is also interested in translational biomedical research, biotechnology, and the development of advanced cell-based therapies